Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Does Clinical Inertia Vary According to Provider Type?

Literature DB >> 22247610

Does Clinical Inertia Vary According to Provider Type?

Daniel G Federman¹, Kirsha S Gordon, Joseph Goulet, Sue Kancir, Woody Levin, Shawn L Fultz, Amy C Justice.

Abstract

Despite the well established risks of persistently elevated blood pressure, as well as the benefits of controlling such elevations, hypertension remains underdiagnosed and undertreated. These VA researchers compared the rates of antihypertensive medication intensification between resident physicians, midlevel practitioners, and attending physicians.

Entities: Disease

Year: 2008 PMID： 22247610 PMCID： PMC3255094

Source DB: PubMed Journal: Fed Pract ISSN： 1078-4497

Keyword Cloud
References

21 in total

1. Demographics and cardiology, 1950-2050.

Authors: D K Foot; R P Lewis; T A Pearson; G A Beller
Journal: J Am Coll Cardiol Date: 2000-03-15 Impact factor: 24.094

2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors:
Journal: JAMA Date: 2001-05-16 Impact factor: 56.272

3. An overview of the meta-analyses of the hypertension treatment trials.

Authors: M Moser; P Hebert; C H Hennekens
Journal: Arch Intern Med Date: 1991-07

4. Inadequate management of blood pressure in a hypertensive population.

Authors: D R Berlowitz; A S Ash; E C Hickey; R H Friedman; M Glickman; B Kader; M A Moskowitz
Journal: N Engl J Med Date: 1998-12-31 Impact factor: 91.245

5. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:
Journal: JAMA Date: 2002-12-18 Impact factor: 56.272

6. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors:
Journal: JAMA Date: 1991-06-26 Impact factor: 56.272

Does Clinical Inertia Vary According to Provider Type?

1. Demographics and cardiology, 1950-2050.

2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

3. An overview of the meta-analyses of the hypertension treatment trials.

4. Inadequate management of blood pressure in a hypertensive population.

5. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

6. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

7. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus.

Review 8. Systolic hypertension in older persons.

9. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes.

10. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.